|
|
|
|
ARMA Newsletter January 2022
|
|
|
|
|
|
We all look forward to 2022 with some trepidation. We don’t know how much impact Omicron will have on the NHS, the population, and our own families. 2021 was a year of challenge and also of incredible achievements. A vaccination programme which has now provided all adults with the opportunity for three doses, four in some cases; which has delivered boosters to three quarters of the eligible population; which delivered 1.6 million boosters in the final week of the year. None of this just happened. It was a success because of people who worked on Christmas day to deliver vaccinations, who volunteered in vaccination centres on top of their day jobs, who dropped everything to rapidly scale up the programme at a moment’s notice.
|
|
|
|
|
|
Working in partnership to reduce inequalities in MSK health
|
|
|
|
Guest blog by Adanna Williams, BestMSK Health Collaborative, Deputy Director
|
This week many of us are returning to work or starting our first week of 2022 having had a difficult Christmas period supporting and delivering services. I am mindful that the impact of focusing efforts to combat the Omicron variant has the potential to widen health inequalities. I have acknowledged how challenging this can be for those who need to access our services and those who are awaiting interventions.
|
|
In the BestMSK Healthcare Collaborative programme (an NHS England and Improvement programme), equality, diversity and inclusion (EDI) continues to be a key priority. We are committed to investigating and understanding all the groups most at risk of health inequalities who need our services. We are using a population health management approach and developing regional MSK networks to achieve this. This way we can understand areas that are working well and those to prioritise for improvement.
|
|
|
|
|
|
ARMA publishes health equalities roundtable report
|
|
|
ARMA published a report on health equalities following a roundtable event. The report highlights solutions and recommendations focussed on MSK health equalities. It is well known that the prevalence and impact of musculoskeletal conditions are not experienced equally across the population. Musculoskeletal conditions are linked to deprivation, age, are more prevalent in women, and disproportionately affect some ethnic groups.
|
|
|
|
|
ARMA publishes chronic pain resources
|
|
Last month ARMA published a suite of chronic pain resources to address the 15.5 million people and 81% of people with a musculoskeletal condition reporting being in chronic pain. Chronic (persistent or long-lasting or recurrent) pain is life-changing and can affect all parts of life. Chronic pain is linked to deprivation and health inequalities. For these reasons, chronic pain is important to the ARMA alliance of members.
|
ARMA members have collaborated to produce these resources:
|
This sets out what ARMA believes should be available in every area for people living with long term pain. Most of this provision needs to be delivered locally, as close as possible to people. We believe that every local health body (ICS, Health Board or Health and Social Care Trust) should have a plan for how this will be delivered. Read the "Core Offer".
|
ARMA Chronic Pain Policy Position Paper
|
The policy position paper makes recommendations for chronic pain including that more community-based approaches to pain should be developed to meet the needs of people with chronic pain. Multidisciplinary, networked, personalised approaches to pain should be standard.
|
|
|
|
|
ARMA welcomes new associate member
|
|
|
ARMA is pleased to welcome new associate member AbbVie to its membership. AbbVie is a research-based biopharmaceutical company discovering and delivering transformational medicines and products in several key therapeutic areas such as immunology. AbbVie invests in research to discover, develop and deliver new medicines.
|
They target diseases with significant unmet need where we can improve the standard of care with innovative new therapies. They aim to create solutions that go beyond treating the illness to have a positive impact on patients’ lives, on societies—and on science itself.
|
|
|
|
|
|
Webinars to watch
|
If you missed our last webinar, it’s available to watch again:
|
|
|
|
|
|
Key MSK COVID-19 resources
|
|
ARMA continues to keep its COVID-19 resources page up to date.
|
|
|
Members' news
|
|
|
|
Online Pain Toolkit workshop
|
|
Online Pain Toolkit workshop for UK and English-speaking EU residents
Presented by The Pain Toolkit - the home of supported pain self-management.
|
Many people may not have access to pain management programmes and so the Pain Toolkit has organised a team of experiences coaches to run a 5-day (2.5hrs a day) workshop. The workshop is open to people living with persistent pain…
|
|
|
|
PCRMM Society NEIAA webinar
|
|
PCRMM webinar: National Early Inflammatory Arthritis Audit (NEIAA)
18 January 2022, 7 – 8.30pm
|
PCRMM is delighted to have the Audit’s Clinical Director, Dr Jo Ledingham, opening the Society’s 2022 series of webinars with this extremely interesting talk about the background of the national early inflammatory arthritis audit (NEIAA). Dr Ledingham will be justifying the need for and the potential benefits of the Audit…
|
|
|
|
|
|
Hope on the horizon for immuno-suppressed/compromised individuals
|
The National Rheumatoid Arthritis Society, in partnership with ARMA, delivered a Facebook live session on vaccination and new COVID-19 treatments aimed at anyone who is immunosuppressed.
|
|
Watch the recording to learn about a new scheme to rapidly get treatments to those who are immunocompromised and a trial of treatments for those over 50 or with certain risk factors.
|
|
|
|
|
|
|
APPG for Osteoporosis and Bone Health Inquiry Report
|
The All Party Parliamentary Group (APPG) for Osteoporosis and Bone Health published a report into the long-standing postcode lottery in the NHS for osteoporosis care. The report highlights the scale of under-diagnosis, under-treatment and missed opportunities in the NHS, with a blueprint for change. Implementation of the blueprint in England and Wales could save the NHS around £287m over five years – a return on investment of around 3:1 – according to the Royal Osteoporosis Society (ROS), which has supported the Inquiry. The report highlights the deep inequalities for access to a Fracture Liaison Service (FLS) …
|
|
|
|
|
|
Orthopaedic recruitment during COVID
|
NOA Webinar: COVID Orthopaedic Recovery: National and International recruitment
|
The first National Orthopaedic Alliance webinar for 2022 will look at national and international recruitment.
Probably the biggest issue impeding orthopaedic surgery recovery is staffing. Many members of staff have left the NHS, retired early or have long term medical and/or mental health issues that limit their ability to work.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
BMP Grant 2021-2022 is now open for applications
|
The application period for the third edition of the Brain Mind Pain Grant (2021-2022) started on 30 November 2021 and runs until the end of March 2022.
|
The BMP Grant aims to support projects that will help improve the quality of life of people living with brain, mind, and pain conditions. The theme of the third edition of the BMP Grant is prevention and self-management. It has been decided to narrow the focus to ‘Healthy Sleep for People Living with Brain, Mind and Pain Conditions’. …
|
|
|
|
|
Psychosocial factors and workplace MSK report
|
Psychosocial risks and work-related musculoskeletal disorders: exploring the links and prevention strategies
|
A new report explores the connections between psychosocial factors and musculoskeletal disorders (MSDs) in the workplace using data from the latest European Working Conditions Survey and European Survey of Enterprises on New and Emerging Risks. It finds that some psychosocial factors — such as working time, job security …
|
|
|
|
|
|
|
|
|
PROP-OA knee pain trial
|
How a research trial will support people living with knee pain and osteoarthritis though advice, exercise and knee braces
|
Knee pain affects one in four people over 45 years in the UK. The most common cause is osteoarthritis, but many people will suffer without getting the diagnosis. Osteoarthritis and its symptoms vary a lot and negatively affect people’s daily lives.…
|
|
|
|
|
Psoriatic Arthritis PSP infographic
|
Final update on the James Lind Alliance Psoriatic Arthritis Priority Setting Partnership
|
During the last two years the researchers running the James Lind Alliance Priority Setting Partnership have explored unmet needs in psoriatic arthritis, determining what is important for people living with psoriatic arthritis, their families and carers, and the healthcare professionals treating them.
|
|
|
|
|
£4 million research funding opportunity
|
The Nuffield Foundation, in partnership with Versus Arthritis, has announced £4 million for new research funding to improve the social and economic wellbeing of people living with musculoskeletal conditions in the UK. Applicants should develop interdisciplinary proposals that can help identify, develop and enhance non-clinical policy and practice interventions.
|
|
|
|
|
|
|
|
ARMA Calendar
| 13 Jan 2022, 6-8pm |
Versus Arthritis Chronic pain and the NICE guidelines webinar |
| 18 Jan 2022, 6-8pm |
Versus Arthritis Core Skills in MSK Care digital course |
| 18 Jan 2022, 7–8.30pm |
PCRMM webinar: National Early Inflammatory Arthritis Audit |
| 25 Jan 2022, 6-8pm |
Versus Arthritis Core Skills in MSK Care digital course |
| 31 Jan 2022 |
Online Pain Toolkit workshop begins |
| 1 Feb 2022, 6-8pm |
Versus Arthritis Core Skills in MSK Care digital course |
| 8 Feb 2022, 6-8pm |
Versus Arthritis Core Skills in MSK Care digital course |
| 16 Feb 2022, 1pm |
NOA Webinar: COVID Orthopaedic Recovery: National and International recruitment |
| 14 March 2022 |
Nuffield Foundation deadline for outline applications |
| 15 March 2022 |
Edgar Stene Prize winner announcement |
| 24 March 2022, 2-4pm |
‘Is it inflammatory arthritis or fibromyalgia syndrome?’ webinar |
| 31 March 2022 |
BMP Grant closes for applications |
|
|
|
|
|
|
We know that many people value our newsletter, webinars and the fact that we provide a voice for MSK health. We are increasingly asked: given that our membership is made up of organisations, how can an individual support ARMA? For this reason, we have set up a new supporter scheme.
|
|
|
|
|
|
|
|
|
|
